Biden Proposal to Lower Medicare Eligibility to 60 Could Benefit MA Insurers

Former Vice President Joe Biden, the de facto Democratic nominee for president, said on April 9 that he will work to lower the eligibility age for Medicare to 60 if elected. In a blog post laying out his plans to tackle COVID-19 and the resulting economic contraction, Biden positioned the Medicare proposal as part of his larger health care reform program, which would include a universal public insurance option.

The proposal was light on details, but it suggested a 60-year-old enrollee would enjoy identical benefits as existing Medicare beneficiaries. “Under this concept, Americans would have access, if they choose, to Medicare when they turn 60, instead of when they turn 65. Medicare benefits would be provided to them as they are to current Medicare recipients,” Biden wrote in the post, which appeared on the online publishing platform Medium.

0 Comments
© 2024 MMIT
Peter Johnson

Peter Johnson

Peter has worked as a journalist since 2011 and has covered health care since 2020. At AIS Health, Peter covers trends in finance, business and policy that affect the health insurance and pharma sectors. For Health Plan Weekly, he covers all aspects of the U.S. health insurance sector, including employer-sponsored insurance, Medicaid managed care, Medicare Advantage and the Affordable Care Act individual marketplaces. In Radar on Drug Benefits, Peter covers the operations of (and conflicts between) pharmacy benefit managers and pharmaceutical manufacturers, with a particular focus on pricing dynamics and market access. Before joining AIS Health, Peter covered transportation, public safety and local government for various outlets in Seattle, his hometown and current place of residence. He graduated with a B.A. from Colby College.

Related Posts

supreme-court
October 4

Will Supreme Court Review Preventive Services Coverage Case?

READ MORE
medicare-advantage-sign
October 4

MA Star Ratings Drama: Humana Gets Bad News, UnitedHealth Sues CMS

READ MORE
wall-street-sign
October 4

Unsurprising or Unlikely? Analysts React to Prospect of CVS Breakup

READ MORE

GAIN THERAPEUTIC AREA-SPECIFIC INTEL TO DRIVE ACCESS FOR YOUR BRAND

Sign up for publications to get unmatched business intelligence delivered to your inbox.

subscribe today